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1. Introduction
Stem cells, characterized by their ability for self-renewal and differentiation, have been derived
from the embryo and from various postnatal animal sources. They are usually classified
according to their developmental potential. Totipotency is defined as the ability of a single cell
to replicate and produce all differentiated cells in an entire organism, including extraem‐
bryonic tissues that will develop and differentiate into the fetal placenta and fetal membranes
[1,2]. In plants, spores are totipotent cells. In some cases, cells can de-differentiate and regain
their totipotency. For instance, a plant cutting or callus can be utilized to grow an entire
functional plant [3]. In mammals, only the zygote and early blastomeres are totipotent cells
[4-7]. In other words, an individual cell is capable to generate a functionally normal animal
with fertile ability [8-10]. Mouse embryonic stem (ES) cells, typically derived from inner cell
masses (ICMs) or corresponding earlier blastomeres or later epiblasts (develop to embryo
proper), are an example of pluripotent cells that can self-renew and generate all types of body
cells in vivo and in vitro, but cannot generate the extraembryonic trophoblast lineage [11-14].
Under some particular conditions, an ES cell-derived mouse with germline transmission can
be generated routinely [15-21]. Multipotent cells, such as hematopoietic stem cells, can give
rise all cell types within a particular lineage. Spermatogonial stem cells are unipotent stem
cells, as they can only form sperm [22].
In recent years, major improvements in deriving mouse ES cell (ESC) lines have dramatically
increased success rates. Therefore, this chapter reviews and discusses the conditions and
techniques for derivation and cultivation of mouse ES cell (mESC) lines. Thereafter, a proposed
novel and user-friendly protocol that is efficient, reproducible, easy to carry out and relatively
cheap is presented.
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2. Conditions for derivation of mouse embryonic stem cells (mESCs)
Since the first mouse ES cell lines were described [23,24], various empirical combinations of
conditions and techniques for derivation and cultivation of mESCs from blastocysts and
isolated ICMs have been developed [25-27]. Of which, selected batches of fetal bovine serum
(FBS), inactivated STO (a SIM mouse embryonic fibroblast line resistant to 6-thioguanine and
ouabain) or murine embryonic fibroblast (mEF) feeder cells, conditioned media, mouse strains,
embryo status, and different small growth areas of wells to initiate cultivation are the principal
concerns when deriving mESCs [27].
To support fetal growth and development, FBS contains mixed combinations of cell replication
stimulators and cell differentiation inducers. Notably, FBS is a biological product, such that its
biopotency to support mESCs varies from batch to batch. Therefore, to circumvent interference
from differentiation factors and other disadvantages associated with FBS, chemically defined
KnockOut™ serum replacement (KSR) [28] and N2B27 [29,30] were developed to replace FBS.
That is, when culturing established mESCs, KSR and N2B27 are usually as effective as FBS.
Unfortunately, embryos in the KSR ESC medium do not result in effective derivation of ESCs
[28,31]. However, a chemically defined ESC medium containing differentiation inhibitors has
much better efficiency than the FBS ESC medium when deriving mESCs [31].
Zygotes to hatched embryos and blastomeres, ICMs, or epiblasts of early-stage embryos can
be used to establish mESCs [31,32]. These cells have extremely high capability for cell division
and differentiation. Theoretically, inhibiting endogenous differentiation and maintaining or
enhancing proliferation of pre-implantation embryos can be helpful for the establishment of
ES cell lines. In 1988, researchers have found that leukemia inhibitory factor (LIF) assists in the
derivation and maintenance of mESCs pluripotency [33,34]. However, when protocols and
media containing LIF for mESCs derivation are applied to mouse strains other than 129s,
efficiency declines from about 20% to less than 5% [35-38]. Furthermore, ESC media supple‐
mented with LIF are not good for deriving ESCs other than mESCs [39,40]. Since then,
regulatory mechanisms, pathways, and signal transduction of self-renewal, differentiation,
proliferation, and apoptosis have been investigated [41,42]. Additionally, the corresponding
synthesized inhibitors and/or stimulators/inducers/enhancers of stem cells [43-47] have been
investigated intensively.
In the early 1990s, as the specificity of developed inhibitors was not sufficiently strong, their
effectiveness in inhibiting differentiation and then helping to establish mESCs were not
satisfactory and culturing results were inconsistent. More recent year, a breakthrough result
was reported. Following the progresses, using the novel mitogen-activated protein kinase
(MAPK)/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor PD0325901 or
SU5402 to eliminate differentiation-inducing signaling from MAPK and using the glycogen
synthase kinase 3 (GSK3) inhibitor CHIR99021 to enhance ESC growth capacity and viability
helped dramatically in establishing mESC lines [48]. Accordingly, ES cell lines of the second
mammalian species (rat) with germline transmission have been reported [49,50]. The combi‐
nation of MEK inhibitor PD0325901 and GSK3 inhibitor CHIR99021 (2i) also appears to
improve the generation efficiency of induced pluripotent stem cells (iPSCs) [51].
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To date, the success rate in establishing mESCs via whole embryos is usually more than 50%,
regardless of the mouse strains used [31,52-58]. Further progress in the derivation of mESCs
from whole early-stage embryos seems limited. Conversely, the success rate in establishing
mESCs via isolated single blastomeres is relatively low and highly variable [31,59]. Although
the success rates in some reports are approximately 30% [59,60], it cannot be the routine yet
due to the variable results.
2.1. Fetal bovine serum (FBS) vs. serum replacement (SR)
To date, FBS, with its excellent nutrient mixture, remains the most important and universal
component for propagating cells. Additionally, FBS contains growth factors that support ESCs.
However, FBS also contains potential differentiation factors for ESCs [61-64]. Therefore, testing
and then selecting batches of FBS to support the growth of undifferentiated ESCs is necessary.
Otherwise, qualified ESC-grade FBS, which is more costly than conventional FBS, can be used.
To support mESCs, the biopotency of FBS (a biological product) varies from batch to batch.
Additionally, its supply worldwide is sometimes limited and it is expensive. Furthermore,
animal-originated materials risk introducing adventitious agents into a cell culture system.
Therefore, to circumvent interference from differentiation factors and other disadvantages of
FBS, chemically defined KSR was developed for use in place of FBS [28].
Although KSR is a commercial product, its formula remains unknown. With its well-defined
chemical formula, N2B27, can replace KSR and achieve almost the same deriving and main‐
taining ESCs results [48,65]. Originally, N2B27 is an empirically mixed formulation that
provides optimum cell viability and efficient neural differentiation [29,30].
Conventional ESC media usually contain 15–20% FBS or 10% FBS plus 10% newborn serum.
For a chemically defined ESC medium, FBS can be replaced completely by KSR or N2B27;
otherwise, 5–15% FBS can be replaced by SR. When changing FBS to a new batch, the ESCs
sometimes have to adapt gradually to the new batch. For example, one can mix 50% old FBS
with 50% new FBS and allow the ESCs to acclimatize to the new medium. Generally, ESCs can
be changed easily from serum replacement (SR) to FBS ESC media by sequential adaptation
with approximately three passages. Reversely, acclimatizing ES cells from the FBS to the SR
ESC medium is sometimes difficult and can fail. When one is switching to a serum-free cell
culture, sequential adaptation for approximately 4–5 passages is required.
Notably, FBS, a good buffer, is a complex solution that contains many chemicals and proteins
with different molecular weights. Therefore, mESCs in FBS-free medium are more sensitive to
extremes of pH, osmolarity, enzyme treatment, and mechanical forces. Furthermore, a 5- to
10-fold lower antibiotics concentration is used in an FBS-free medium because serum proteins
typically bind a certain amount of the antibiotic; without these serum proteins, the antibiotic
concentration may be toxic to mESCs.
After passing mESCs in a SR ESC medium, centrifugation is necessary to remove trypsin from
the cell suspension to avoid further digestion of cells due to the lack of trypsin inhibitors in
the medium. For convenience, enzymes that can stop digestion due to the decreased concen‐
tration will be a good alternative to trypsin. TrypLE™, a recombinant enzyme derived from
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microbial fermentation, can stay at room temperature (RT) before expiration. My laboratory
routinely uses TrypLE™ Express to pass mESCs during derivation and maintenance with good
outcomes [31].
2.2. Feeder cells
The ESCs are extremely sensitive to culture conditions, including properties of culture media
and dishes, when maintaining pluripotency without differentiation. Unfortunately, commer‐
cially available plates and dishes are not adequate for ESCs.
In the 1970s, pluripotent teratocarcinoma (stem) cell lines were established after introduction
of a cell feeder layer [66-68]. Feeder (helper) cells have since been used to help study terato‐
carcinoma stem cells and embryonal carcinoma (EC) cells. The STO feeder cells then demon‐
strated to help derive the first mESCs [23] and maintain mESCs at the undifferentiated state.
Feeder cells are usually inactivated via mitomycin C or γ-irradiation treatment. While γ-
irradiation leads to breaks in DNA strands, mitomycin C has the extraordinary ability to
crosslink DNA with high efficiency and is specific for the CpG sequence [69,70]. Although
feeder cells are alive, they do not replicate but gene transcription and protein synthesis are not
affected.
It has been speculated that feeder cells support embryos and ESCs attachment through the
physical matrix [71]. Furthermore, feeder cells may release embryo trophic factors, reduce
inhibitory or toxic factors in FBS, or may be beneficial by lowering concentrations of ions and/
or glucose in medium, and thereby overcoming the developmental blockage of embryos
mediated by the release of growth factors essential for activation of the embryonic genome
and for normal embryonic development. Additionally, feeder cells may protect embryos from
oxygen toxicity [63].
Various feeder cells, which differ in their ability to support ESCs, have been utilized to
establish, propagate, and maintain the pluripotency of ESCs [35,72]. Conventionally, STO and
mEF are the most popular feeder cells for deriving and maintaining ESCs. However, human
foreskin fibroblast (hFF) feeder cells also support propagation and self-renewal of human
[73-76] and mouse ESCs [31,77].
As feeder cells at earlier passages are used, their ability to support ESCs is increased [78].
Reports have demonstrated that mEF, STO, and hFF feeder cells secrete different growth
factors to support ESCs [76,77,79-81].
To help establish mESCs, the STO, mEF, and hFF feeder cells might have roughly equal
efficiency [31,82]. Recently, a study reported that hFF supported mESC self-renewal superiorly
to mEFs due to the convenience. Using the hFF system, multiple lines of mESCs have been
successfully derived without addition of exogenous LIF and any inhibitors. These mESCs have
capacities to self-renew for a long period of time and to differentiate into various cell types of
the three germ layers both in vitro and in vivo [76]. The STO is a cell line (ATCC No. CRL-1503)
for unlimited propagation. The hFF may be a cell line (CCD-1112Sk, ATCC No. CRL-2429;
Hs68, ATCC No. CRL-1635; HFF-1, ATCC No. SCRC-1041) or primary cells. The mEF is
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primary cells harvested from fetuses approximately 12.5–13.5 days post coitum (dpc). How‐
ever, mEF can be passed and propagated only for a short period [83-85]. Therefore, they must
be prepared continuously. Additionally, the traits of mEFs differ from batch to batch, and
quality control of mEFs, especially for mycoplasma contamination, may be the problems
[86,87]. Moreover, hFFs are more durable than mEFs in that they remain in healthy condition
more than 2 weeks after inactivation by radiation. In contrast, mEF deteriorates within 1 week
after the inactivation [76].
To derive and maintain mESCs, feeder cells and ESC medium supplemented with LIF (typical
concentration is 1,000 unit/mL) are usually chosen. The reason is due to the LIF produced by
mEFs and STO is not enough to maintain ESC properties most of the time. However, recombi‐
nant murine LIF is expensive. Therefore, STO that expresses a high level of LIF (SNL76/7,
ATCC No. SCRC-1049; SNLP 76/7-4, ATCC No. SCRC-1050) has been developed [88]. This cell
line also can be used as a feeder layer supporting the derivation and growth of mESCs and
iPSCs [89]. The disadvantage of the SNL76/7 as a feeder cell is the highly variable level of LIF
in culturing medium, that might have different effects on mESCs [24,56,57,90-93].
2.3. Conditioned media
Both teratocarcinoma stem cells and EC cells were established in the 1970s [66,94-96]. Both
pluripotent cells usually undergo extensive differentiation in vivo and in vitro to generate a
wide variety of cell types [97]. Mouse teratocarcinoma stem cells can condition themselves.
Therefore, medium conditioned with teratocarcinoma stem cells, which is equivalent to a 5-
fold concentration of LIF [92], was used to help establish mESCs [24]. Thereafter, the propa‐
gation of mESCs in high densities reduces possible differentiation [26,98].
Feeder cells secrete many different factors, including growth factors, to support ESCs
[76,77,79-81]. The recovered conditioned medium is a complex solution containing many
unidentified chemicals. However, as conditioned media are exhausted media prepared in a
batch-by-batch manner, their biopotency might vary. The question is whether conditioned
medium is still needed to derive ES cells when chemically defined ESC media supplemented
with differentiation inhibitors and growth factors are available.
A few different conditioned media have been used to establish mESCs. Of which, an FBS ESC
medium conditioned by a rabbit fibroblast cell line transduced with genomic rabbit LIF (10
ng/mL) allows efficient derivation and maintenance of mESC lines from all 10 inbred mouse
strains tested, including some that were presumed nonpermissive for mESC derivation [56].
This commercialized conditioned medium, RESGROTM Culture Medium (Millipore), can
establish and rescue established mESCs that have started drifting, and either generate low-
percentage chimeras or lose their germline transmission capability [53,92].
2.4. Mouse strain and embryo status
Teratomas (benign) and teratocarcinomas (malignant) are tumors composed of an ectoderm,
endoderm, and mesoderm mixtures of adult tissues [99]. Most are found in gonads and rare
in mammals, including experimental animals. In the 1950s, mouse strain 129 had found an
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incidence of spontaneous testicular teratoma of about 1% [100]. After progress and refinement
of cell culture techniques, most notably the introduction of the cell feeder layer, allowed the
reliable cultures of pluripotent teratocarcinoma (stem) cell lines [66-68].
The mESCs were first derived from 129SvE [23] and then (ICR × SWR/J) F1 hybrid embryos
[24]. However, due to the demand for animal models of human diseases, strains other than
129s have been used to establish new mESC lines. Unfortunately, the following mESCs were
derived mainly from 129 strains due to the permissive nature of the genetic background
[27,32,35,38]. The derivation of mESCs from blastocysts is a process that is often very ineffi‐
cient, and even in the most favorable 129 strains, a success rate of 30% is regarded as high [26].
Derivation of mESCs is strongly mouse strain–dependent [32], and in practice the efficiency
of derivation in strains other than 129 strains does not usually exceed 10% [36].
Strains other than 129s, such as FVB, CBA/Ca, and the non-obese diabetic (NOD) mouse [101],
have the extremely low derivation rates of mESCs using conventional conditions. They are
traditionally regarded as highly refractory (nonpermissive) for derivation of mESCs. More‐
over, they also produce chimeras either incapable of germline transmission [102] or restricted
in their germline competence [37].
Mouse strain C57BL/6 (B6) is not usually considered as a permissive strain for mESC deriva‐
tion. Although the B6 mES cell lines have been available since the early 1990s [35,103], the
efficiency in establishing B6 mESCs via FBS or KSR ESC medium containing LIF varies and is
typically less than 10% [32,38,56,61,82,103-109]. When establishing C57BL/6J mESCs using FBS
(15%) ESC medium containing LIF, the highest success rate was 40% (36/89) [56]. Notably, this
study used mEF feeder cells coated on 96-well cell plates for initiation of blastocysts and
thereafter digested ICM outgrowths cultured at 39°C under 5% CO2 in an incubator. In
establishing B6 mESCs using KSR (20%) ESC medium containing LIF, the derivation rate of
(C57BL/6N × C57BL/6J) F1 mES-like colony can be as high as 40% (10 of 25 blastocysts) [109].
Other studies also demonstrated that the efficiency in establishing mESCs is significantly
higher for the C57BL/6N strain (53%) than for the C57BL/6J strain (20%) [109]. Recently, my
study showed that C57BL/6J blastocysts in KSR ESC medium did not lead to effective deriva‐
tion of mESCs; however, the success rate in 2i medium was as high as 75%. Furthermore, the
efficacy of 2i medium was also demonstrated when using morulae (60%) and 8-cell embryos
(50%) for mESCs derivation [31].
Although previous results suggested that true ES cells can be derived from embryos explanted
at any stage of preimplantation development in the mouse [110]. My laboratory was the first
to report success in deriving mESCs from mouse zygotes. These zygote-derived mESCs are
morphologically indistinguishable from mESCs derived from fertilized embryos and blasto‐
meres. Moreover, the generation of germline transmitted chimeras confirmed that the estab‐
lished mES-like cells are pluripotent mESCs [31].
In recent years, the mESC lines of nonpermissive strains have been established routinely from
3.5 dpc blastocysts when SR ESC medium containing differentiation inhibitors and/or prolif‐
eration enhancers was used.
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Typically, diploid male mESCs capable of a high percentage generation of chimeras with
germline transmission are selected for further utilization. However, some unusual mESCs
have been reported including the androgenetic [111], germline transmitted female [112], adult
somatic cell nuclear transferred [113], XO [114], parthenogenetic [115], haploid [54], and
androgenetic haploid [116] mESCs.
2.5. Single blastomere
To date, most available ES cell lines were derived from the outgrowth of ICMs of blastocysts.
However, due to ethical concerns over the derivation of human ES (hES) cells for regenerative
medicine, a single blastomere (usually from 8-cell embryos) has been utilized to derive ESCs.
Unfortunately, conventional methods used to establish mESCs directly from an isolated single
blastomere, which is extremely sensitive to culture conditions, are unsuccessful. Actually, most
of the isolated blastomeres divide to form small sheets of cells with a trophoblastic-like
morphology or small blastocysts with or without visible ICM-like cells [6,31,117]. In 1996, mES-
like cells were first reported from single blastomeres [118]. Since then, no ESCs were estab‐
lished from blastomeres until 2006 [117].
The mESCs can condition themselves to inhibit or prevent differentiation. Therefore, blasto‐
meres aggregated with established mESCs for initial co-culturing to help in the derivation of
mESCs is a logically reasonable alternative. In this manner, the single blastomere-derived
mESCs have been established but overall success rates are less than 5% when using the
conventional FBS ESC medium [117-119]. In spite of that, a possibility may exist for deriving
personalized hES cells without destruction of 8-cell embryos.
On 2004, the study showed that the KSR ESC medium do not support mES single cell culturing.
Contrary, single mESCs were propagated without loss of pluripotency when the adrenocor‐
ticotropic hormone (ACTH) was added to KSR ESC medium [62]. The authors of that study
hypothesized that ACTH may be integrated via a weak cross interaction with an unknown,
non-physiological inhibitory G protein coupled receptor. A signaling system other than the
cAMP-PKA pathway or PKA pathway may play an important role in propagation of mESCs
[62]. Later, simple and efficient establishment of mES cell lines from a single blastomere of 2-
to 8-cell embryos with KSR ESC medium containing ACTH fragments 1–24 (ACTH 1–24) on
mEF feeders was reported [59].
Wakayama et al. (2007) developed a novel protocol and established mESCs via blastomeres
and polar bodies. In their experiment, isolated B6D2F2 blastomeres were cultured on KSR
(20%) ESC medium containing ACTH 1–24 in 96-well plates coated with mEFs. The mESC
establishment rates were 33%, 8%, and 8% for blastomeres derived from 2-cell (1/2), late 4-cell
(1/4), and 8-cell embryos (1/8), respectively. However, they did not aggregate blastomeres with
other mESCs, suggesting that success was likely attributable to the KSR ESC medium con‐
taining ACTH 1–24 [59]. Other studies then demonstrated that mESCs can be established from
1/2, 1/4, 2/4, 1/8, 2/8, 3/8, and 4/8 blastomeres in medium containing ACTH 1–24 [31,120-122].
For blastomeres, as the developmental stage of embryos decreases and the number of isolated
blastomeres used increases, the derivation efficiency of mESCs increases. Moreover, whole
embryos always have better derivation efficiency than corresponding blastomeres. Further‐
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more, KSR ESC medium containing differentiation inhibitors and/or proliferation stimulators
is better than FBS ESC medium in establishing mESCs.
For ethical concerns, such as maintaining the developmental potential of embryos and
establishing corresponding hES cells, a 1/8 blastomere is one of the best candidates. Unfortu‐
nately, derivation efficiency of mESCs via a 1/8 blastomere is usually approximately 5–10%,
such that it cannot be a standard protocol for the routine operation. Obviously, reliable and
efficient protocols for ESCs derivation should be developed.
Previous studies have indicated poor derivation efficiency of mESCs from a 1/8 blastomere,
partly due to the low division rate of single blastomeres when compared to that of their
counterparts with a higher number of blastomeres (2/8, 3/8, and 4/8). Communication and
adhesion between blastomeres, from which the derivation process begins, are likely important
aspects to efficiently deriving mESC lines. Therefore, an approach consisting of chimeric E-
cadherin (E-cad-Fc) adhesion to the blastomere surface has been devised to recreate the
signaling produced by native E-cadherin between neighboring blastomeres inside an embryo.
Via this approach, the 1/8 blastomere incubated with E-cad-Fc for only 24 h can significantly
improve the mESC derivation efficiency from 2.2% to 33.6% [60]. To date, this novel method
via 1/8 blastomere has the best derivation efficiency for mESCs. However, its reproducibility
must be confirmed by other laboratories.
2.6. Pluripotent signaling pathways
In 1988, two studies demonstrated that LIF could assist in derivation and maintenance of the
pluripotency of mESCs [33,34]. Unfortunately, following studies revealed that LIF is not as
effective or good for mammals other than mice in establishing ESCs. These experimental
results implied that different mammals might have different regulatory mechanisms for ESCs.
Actually, distinct signaling pathways have been shown to regulate the pluripotency of mouse
and human ESCs [41,42,123].
The regulatory mechanisms and signal transductions of self-renewal, differentiation, prolif‐
eration, and apoptosis [41,42,124], as well as the corresponding inhibitors of stem cells [43-47,
125] have been investigated (Figure 1).
To date, self-renewal, pluripotency, and the propagation signaling transduction pathways of
ESCs includes the LIF/signal transducer and activation of transcription 3 (STAT3), Wnt/β-
catenin, phosphatidylinositol 3-kinase (PI3K), bone morphogenic protein 4 (BMP4)/Smad1/5,
and basic fibroblast growth factor (bFGF) [42,45]. Conversely, the Ras/Raf/MEK/ERK pathway
is central to the signaling networks that govern proliferation, differentiation, and cell survival
[126]. The active Ras/Raf/MEK/ERK pathways induce differentiation of mESCs [42,124,126].
The mESCs have high ERK activity when they undergo differentiation. Suppression of the ERK
pathway promotes self-renewal of mESCs. Moreover, BMP4 activation inhibits differentiation
of mESCs in medium containing LIF due to inhibitor of differentiation (Id) genes expression
and ERK inactivation [127-129].
Of the many pathways, self-renewal of mESCs largely depends on LIF/interleukin 6 (IL-6)
family members [130] and BMP4 [65,127]. LIF binds to a cell surface complex composed of the
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LIF receptor and the transmembrane signaling molecule gp130, resulting in activation of
transcription factor STAT3, which is essential and sufficient to promote self-renewal and
inhibit mesoderm and endoderm differentiation of mESCs [125,130-132]. Additionally, Wnt
signaling inhibits GSK3β and results in the protein stabilization of cytoplasmic β-catenin (β-
Ctnn). The GSK3, a constitutively acting multi-functional serine threonine kinase, derives its
name from its substrate glycogen synthase, a key enzyme involved in conversion of glucose
to glycogen. Although GSK3 is kept inactive by phosphorylation, activated GSK3 enhances
synthesis of glycogen and inhibits cell proliferation. The name GSK does not adequately
describe the multitude of diverse substrates and functions attributed to GSK3. For instance, it
is involved in various cellular processes, ranging from glycogen metabolism, insulin signaling,
cell proliferation, neuronal function, and oncogenesis to embryonic development [133].
Additionally, GSK3 is one of the crucial molecules involved in regulation of the Wnt/β-catenin,
Hedgehog, and Notch signaling pathways. The undifferentiated pluripotency of both mouse
and human ESCs can be maintained by GSK3-specific inhibitor 6-bromoindirubin-3’-oxime
(BIO), which prevents phosphorylation of β-Ctnn by GSK3β and activates Wnt [134,135]. The
Wnt signaling is endogenously activated in mESCs and is down regulated upon differentiation
[135]. The target genes of the Wnt signaling pathway, such as c-Myc and CyclinD1, promote
cell proliferation and self-renewal. The LIF/STAT3 pathway combines with the Wnt/GSK3β/β-
catenin pathway to enhance self-renewal by activation of pluripotency genes, including
transcription factors Nanog, Oct3/4, and Klf4. Nevertheless, LIF also activates the MAPK/ERK
pathway, which induces mESC differentiation [45].
Figure 1. The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency. (Reproduced
with permission from Sumer et al., 2010. Theriogenology 74:525–533.)
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As a protein, transforming growth factor beta (TGFβ) controls proliferation, cellular differen‐
tiation, and other functions in most cells. This protein is a secreted protein of cytokines. The
TGFβ family is part of the large TGFβ superfamily, which has more than 40 members, including
TGFβ, activin, nodal, BMPs, inhibins, anti-müllerian hormone, decapentaplegic, and Vg-1. All
of these ligands are associated with ESCs. Although BMP4 is a member of the BMP family, it
functions via a different signaling pathway with TGFβ. Notably, BMP4 induces expression of
Id genes and inhibits MAPK signaling as well as neuroectoderm differentiation [65,127].
Although activation of STAT3 is sufficient for self-renewal of mESCs, a study showed that LIF-
STAT3 do not maintain mESCs in serum-free ESC medium. The combination of LIF and BMP4
maintained the self-renewal of mESCs in the absence of both feeder cells and FBS [65,127].
Thus, BMP4 and LIF have synergistic effects on the self-renewal of mESCs [127]. In contrast to
mESCs, BMP4 does not maintain the self-renewal of hES cells; rather, it induces trophoblast
or primitive endoderm differentiation of hES cells [136].
The PI3K pathway is also important for proliferation, survival, and maintenance of pluripo‐
tency, as well as inhibiting apoptosis in ESCs. The ESC-expressed Ras (ERas) is specifically
expressed in ESCs, stimulating PI3K. This PI3K activation promotes ESC proliferation [137]
and self-renewal [138]. Inhibition of PI3K and Akt induces differentiation of mESCs in the
presence of LIF and feeder cells [139], suggesting that PI3K/Akt signaling is necessary for
maintenance of the pluripotency of ESCs.
The ESC can maintain its pluripotency with feeder cells. Exogenous supplementation of LIF
is sufficient to sustain mESCs at undifferentiated state in a feeder cells free condition. However,
LIF is insufficient for maintaining the pluripotency of hES cells. Human ESCs have been most
commonly cultured in the presence of bFGF either on fibroblast feeder layers [140] or in
fibroblast-conditioned medium. The bFGF signaling pathway appears to be important to the
self-renewal of hES cells [141,142]. Reports have shown that bFGF (40 ng/mL) combined with
noggin (inhibitor of BMP4) supports the undifferentiated proliferation of hES cells in the
absence of feeder cells [143-145]. Furthermore, a high bFGF concentration (100 ng/ml) alone is
sufficient to maintain human ESCs [145]. The post-implantation epiblast-derived stem cell
(EpiSC) lines [14] express transcription factors that regulate pluripotency and robustly
differentiate into the major somatic cell types as well as primordial germ cells [12]. Further‐
more, the EpiSCs and hES cells share patterns of gene expression and signaling responses in
the epiblasts [12]. In fact, the similarities (FGF and activin growth factors for self-renewal; in
vitro pluripotency; chimera formation; and spontaneous trophoblast differentiation) between
hES cells and mouse EpiSCs have led to the suggestion that hES cells are equivalent to early
post-implantation epiblasts, rather than their ICM progenitor [146,147].
2.7. Differentiation inhibitors help to derive mouse ES cells
In the early 1990s, as the specificity of developed inhibitors was insufficient, the effectiveness
of these inhibitors to inhibit differentiation and then help to establish mESCs was not satis‐
factory and outcomes are varied. Since the late 1990s, using MAPK/ERK kinases (MEKs)
inhibitors PD098059 [128] and UO126 [41], or by dephosphorylating ERKs by mitogen-
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activated protein kinase phosphatase 3 (MKP-3) [41] enhanced the self-renewal of mESCs and
inhibited their differentiation.
It was the first report showed that the combination of PD98059 (MEK 1 inhibitor) with LIF
enhances the establishment of mESCs from the refractory CBA strain [148]. A combination of
the MEK1/2 inhibitor, U0126, with LIF further promoted the efficiency of mESC derivation
from CBA [129]. These small molecules, PD98059 and U0126, play positive roles in the self-
renewal of mESCs, but they are incapable of maintaining the pluripotency of mESCs in long-
term culture without LIF [48,128,135].
Notably, BMP4 inhibits both ERK and p38 MAPK pathways in mESCs. The inhibitors of the
ERK and p38 MAPKs mimic the effect of BMP4 on mESCs. Inhibition of the p38 and MAPKs
by SB203580 overcomes the roadblock in deriving mESCs from blastocysts lacking a functional
Alk3, the BMP4 type-IA receptor [127].
The self-renewal of mESCs is generally dependent on multifactorial stimulation. To support
the growth and development of fetuses, FBS contains cell replication stimulators and cell
differentiation inducers. Serum and serum substitutes contain various inductive stimuli that
may activate commitment and differentiation programs [49]. However, simple withdrawal of
serum or other exogenous stimuli cannot prevent differentiation of ESCs due to endogenous
autoinductive differentiation of fibroblast growth factor 4 (FGF4) via the MEK/ERK pathway
[48,149]. Therefore, to suppress endogenous autoinductive differentiation and to maintain
high viability and growth rates, one must inhibit the MEK/ERK pathway and/or provide LIF,
or restrict the activity of GSK3, which acts mainly via the Wnt/β-catenin signaling pathway to
suppress cellular biosynthetic capacity, and subsequent cell growth and viability [134,150].
Those studies have demonstrated that inhibition of GSK3 via BIO dramatically augment mESC
derivation from isolated ICMs of both C57BL/6 (76%) [135] and BALB/c (31%) [134].
Through  dual  inhibition  of  the  Ras  GTPase-activating  protein  (RasGAP)  and  ERK1,  a
function-oriented and novel small  molecular pluripotin,  also called SC1, was developed.
By  using  this  novel  pluripotin,  one  can  propagate  mESCs  in  an  undifferentiated  and
pluripotent state under chemically defined conditions in the absence of feeder cells, FBS,
and LIF. Moreover, long-term pluripotin-expanded mESCs can generate germline-transmit‐
ted chimeric mice [43]. By combining pluripotin and LIF for the derivation of mESCs, the
successfully isolated mESCs from five strains of mice; efficiency was 57% for NOD-scid,
63% for SCID beige,  80% for CD-1,  and 100% for two F1 strains from C57BL/6 x CD-1.
Pluripotin  combined with  LIF  improved the  efficiency  of  mESC isolation  by  selectively
maintaining Oct4-positive cells in outgrowths.  This is  the first  work to efficiently derive
mESCs from immunodeficient mice (NOD-scid on an NOD background and SCID beige
on a BALB/c background) on refractory backgrounds [57].
Recently, a novel protocol involves an unusually long initial incubation of 12 days for blasto‐
cysts seeded in 12-well plates coated with mEFs and containing LIF and pluripotin-supple‐
mented KSR ESC medium (15% KSR), which results in the formation of large spherical
outgrowths. These outgrowths are morphologically distinct from classical ICM outgrowths
and can be picked easily and trypsinized. Importantly, pluripotin needs to be omitted after the
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first trypsinization because it blocks the attachment of mES-like cells to the mEF feeder layer;
its removal facilitates the formation of mESC colonies. In addition, pluripotin is harmful to the
mEFs and it is not unusual that half of the mEFs die during the first week. However, this
massive death of mEFs does not affect the mES cell derivation efficiency [55]. I also found that
STO and Hs68 feeder cells were dying when culturing in KSR ESC medium supplemented
with 3 μM pluripotin (unpublished observation). The modified protocol gives rise to mESCs
(more then five passages) in a robust and reliable manner with an extremely high success rate
of 94% (78/83) [55]. Surprisingly, 10 mESCs derived with 4 μM pluripotin showed the chro‐
mosomal instability. All of these cells generated weak chimeras. Thus, these lines are only
suitable for in vitro analysis. In contrast, mES-cell lines derived with 2 μM pluripotin during
the blastocyst outgrowth phase were generated with unusual high efficiency (100%) and these
lines had a normal karyotype. In addition, strong chimeras could be derived from these mESCs
[55]. Yang and colleagues (2009) derived mESCs with 3–5 μM pluripotin. Their mESCs showed
some chromosomal abnormalities and were not proven to be germline competent [57].
Although the derivation of novel mESCs have been improved significantly via differentiation
inhibitors and/or proliferation stimulators, no germline-transmitted ESCs other than the
mESCs have been reported. In recent years, the MEK inhibitor PD0325901 or SU5402 has been
used to eliminate differentiation-inducing signaling from MAPK and the GSK3 inhibitor
CHIR99021 has been used to enhance mESC growth, enabling derivation and propagation of
germline-competent mESCs from CBA and 129 strains in an N2B27 chemically defined ESC
medium. These findings reveal that self-renewal is enabled by the elimination of differentia‐
tion-inducing signaling from MAPK. Additional inhibition of GSK3 consolidates biosynthetic
capacity and suppresses residual differentiation. Complete bypass of cytokine signaling is
confirmed by isolating stat3–/– mESCs [48]. Accordingly, ES cell lines of the second mammalian
species (rat) with germline transmission have been established [49,50].
Recently, my report showed that two C57BL/6J mESCs were derived from two morulae in KSR
ESC medium supplemented with 2i but without LIF [31]. These experimental results confirmed
previous reports indicating that inhibitors that block the MEK/ERK differentiation pathway
can support self-renewal of mESCs, even without LIF signaling [43,48].
The efficiency of establishing mESCs with 2i was not reported [48]. Recently, my experimental
results showed that the efficiency in establishing C57BL/6J ES cells in KSR ESC medium
supplemented with 2i and LIF could be high as 65% for morulae and 70% for blastocysts [31].
Thus, the efficacy of 2i in helping establish mESCs is confirmed.
2.8. Self-renewal and proliferation stimulator
Although a previous study showed that extrinsic stimuli are dispensable for derivation,
propagation, and pluripotency of mESCs [48], the self-renewal and derivation of mESCs
largely depends on LIF [130] and BMP4 [65,127]. When LIF is present at concentrations higher
than those used in routine cultivation (500 unit/mL for the mEF feeder and 1,000 unit/mL for
the STO feeder), the derivation efficiencies of mESCs from refractory strains are improved
significantly [57,91,93]. Indeed, strain difference in response to soluble growth factors is
evident from two original reports of mESC derivation. Evans and Kaufman (1981) established
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mESC lines from permissive 129SvE delayed blastocysts, solely by culturing them on STO
feeder cells. Notably, Martin (1981) was unable to establish mESC lines from immunosurgically
isolated ICMs of (ICR x SWR/J) F1 and (C3H x C57BL/6) F1 fully expanded blastocysts unless
the teratocarcinoma stem cell-conditioned medium, equivalent to a 5-fold LIF concentration
[92], was added. A previous report revealed that a mESC medium containing 10 ng/mL rabbit
LIF or conditioned by a rabbit fibroblast cell line transduced with genomic rabbit LIF facilitates
efficient derivation and maintenance of mESC lines (≥ 10 passages) from all 10 inbred mouse
strains tested, including some that were presumed nonpermissive for ESC derivation [56]. A
more recent study demonstrated that SR ESC medium containing high concentrations of LIF
(2,500 and 5,000 unit/mL) could establish mES cell lines from C57BL/6, Balb/K, nonpermissive
CBA/Ca, and NOD mice [92].
Additionally, another report shows that KSR ESC medium does not support single mESC
culture, likely because this medium lacked some important growth factors or such undefined
factors, such as “stem-cell autocrine factors,” are secreted by mESCs themselves [62]. However,
when KSR ESC medium is supplemented with ACTH, single mESCs are propagated and their
pluripotency is maintained. Accordingly, mESC lines have been established efficiently using
single blastomeres from 2- to 8-cell embryos in KSR ESC medium containing ACTH 1–24 [59].
The CHIR99021 pathway and proposed ACTH pathway likely differ. Therefore, synergetic
effects of 2i (PD0325901 + CHIR99021) and ACTH 1–24 may exist in deriving mESCs. My
experimental results reveal that neither STO nor Hs68 feeder cells coated on 10-μL droplets
and cultured in KSR ESC medium supports effective derivation of mESCs from embryos or
blastomeres of ICR or C57BL/6J. However, by supplementing KSR ESC medium with 2i or
ACTH 1–24, efficiency in establishing mESCs increased dramatically. Experimental results also
demonstrate that inhibiting cell differentiation and increasing cell growth/viability (in the
presence of 2i) simultaneously is better than increasing only cell survival and/or proliferation
(with ACTH 1–24) when deriving mESCs [31]. Additionally, experimental results also suggest
that GSK3 inhibitor CHIR99021 and ACTH 1–24 likely have different pathways in synergisti‐
cally enhancing the establishment of mESCs because 2i with ACTH 1–24 is much more effective
than 2i or ACTH 1–24 alone [31].
2.9. Developing more powerful differentiation inhibitors
A previous study has demonstrated that blastomeres from 2- to 8-cell embryos developed into
blastocysts within 3–5 days in KSR ESC medium containing ACTH 1–24 [59]. Another report
indicates that 2- to 4-cell embryos and blastomeres, which developed into blastocysts in
medium containing ACTH 1–24, PD98059 (MAP2K1 inhibitor) or SB203580 (MAPK14
inhibitor), yields developmental rates comparable to those of the control embryos [151]. My
previous study showed that approximately 60% of 1.5–2.5 dpc denuded whole embryos
developed into typical blastocysts or small blastocysts and approximately 80% of the corre‐
sponding blastomeres developed into small blastocysts within 2–4 days in KSR ESC medium
containing 2i or ACTH 1–24. These experimental results imply that 2i and ACTH 1–24 might
have little or no adverse effect on cell proliferation or the development of embryos and
blastomeres. Furthermore, these observations indicate that 2i, MAP2K1, and MAPK14
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inhibitors are not strong enough to inhibit differentiation of embryos and blastomeres entirely
[31]. I also note that 0.3–3 μM pluripotin did not inhibit differentiation of ICR 2.5 dpc embryos
and blastomeres completely (unpublished observation).
These experimental findings suggest that other more powerful inhibitors, via the Ras-MEK-
ERK signaling pathway or other signaling pathways, may be worth developing to further
enhance the success rate of deriving ESCs. Theoretically, chemical cocktails that completely
inhibit endogenous differentiation, increase cell division, and decrease apoptosis of pluripo‐
tent cells should maximize the derivation efficiency of ESCs. Furthermore, is it possible to
develop novel differentiation inhibitors that maintain the totipotency of very-early-stage
blastomeres?
3. Novel efficient, reproducible, and user-friendly protocol for deriving
mouse ES cells
An excellent protocol for deriving mESCs must be efficient, reproducible, easy to perform, and
relatively cheap.
The following protocol, adopted and minor modified from my previous study [31], has been
used in my laboratory for more than 3 years with reproducible high derivation efficiency
(always more than 50%, occasionally reaching 100%) for 2.5 dpc whole embryos, regardless of
which strains (ICR, B6, ICRB6F1, and B6CBF1) are tested. Moreover, all other pre-implantation
embryos can be used. Although the same protocol can be used to derive mESCs via single
blastomeres, derivation of mESC varies in efficiency, which depends on the origin of blasto‐
meres (approximately 10–30%).
3.1. Growth area for initial cultivation
For initial cultivation of embryos, ICMs, and blastomeres to establish mESCs, different growth
surface areas in multi-well cell plates are used. Of which, the 24-well and 96-well plates are
used mainly. In practice, the amount of medium needed to half fill one well in a 24-well plate
is approximately 0.5 mL and 150 μL for a 96-well plate. Both volumes are enormous to the
mouse embryo (diameter, 85 μm; volume, 320 pL = 0.00032 μL) or 1/8 blastomere (diameter,
20 μm; volume, 4 pL = 0.000004 μL). Furthermore, the height of wells is not user-friendly when
taking photographs or picking growing three-dimensional outgrowths. Therefore, to reduce
the amount of expensive ESC media that is usually exchanged every other day, ease handling,
and increase the disaggregation efficiency of growing three-dimensional outgrowths, different
volumes of micro-droplets were tested. I hypothesize that homemade micro-droplets on cell
culture dishes coated with feeder cells are as effective as cell plate wells for initial cultivation
to establish mESCs. Finally, 10-μL and 20-μL droplets are chosen for initial and for disaggre‐
gated outgrowths cultivation, respectively. Up to 32 10-μL or 24 20-μL feeder droplets on a
60-mm cell culture dish covered with heavy weight paraffin oil can be prepared and used
routinely. My culturing results show that 10-μL droplets support the growth of 2.5 dpc
embryos for at least 7 days and 1/8 blastomeres for at least 10 days (Figure 2).
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Figure 2. The 10-μL droplets are excellent for initial cultivation to derive mESCs. Embryos and blastomeres seeded in
10-μL droplets coated with Hs68 feeder cells in KnockOut™ serum replacement (KSR) ESC medium supplemented
with 0.5 µM PD0325901 (MEK inhibitor), and 3 µM CHIR99021 (GSK3 inhibitor) (2i), 10 µM ACTH–24 (adenylyl cyclase
inhibitor), as well as 1,000 unit/mL LIF support the growth of 2.5 dpc embryos for at least 7 days and 1/8 blastomeres
for at least 10 days. a1, early blastocyst; b1, morula; c1, 2/16—isolated single blastomere that originated from late 8-
cell embryos were divided; d1, 1/8—isolated single blastomere that originated from 8-cell embryos. a2–d2, cultured
for 3 days after initiation of cultivation; a3–d3, cultured for 7 days; and a4–d4, cultured for 10 days; a5–d5, cultured
for 12 days. The bar represents 100 μm.
The previous study reported that the culturing blastocysts allow to hatch and expand for
approximately 6 days; however, the earlier trypsinization (at day 4 or 5) of outgrowths do not
seem to affect efficiency but prolonged the time needed for mESCs derivation [58]. Very
interestingly, blastocyst outgrowths can be cultured in 2 μM pluripotin-containing KSR ESC
medium for 12 days (or up to 18 days) without losing their ability to form mESCs. The main
advantage of a long initial cultivation is to greatly increase the number of cells, which including
undifferentiated cells, before the first trypsinization. The derivation efficiency could be as high
as 94% (78/83) [55].
Further, my experimental results demonstrated that mESCs are established efficiently from
C57BL/6J denuded whole embryos culturing in a 10-μL droplet coated with Hs68 feeder cells
of KSR ESC medium supplemented with 2i, ACTH-24, and LIF (Figure 3) [31].
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Figure 3. The C57BL/6J ES cells derived from 2.5-day post-coitum (dpc) denuded 8-cell embryos or single blastomeres
cultured in 10-µL droplets. a1: An 8-cell embryo cultured in KSR ESC medium containing 0.5 µM PD0325901 (MEK
inhibitor) and 3 µM CHIR99021 (GSK3 inhibitor) (2i) with STO feeders. Images show 2 (a2), 4 (a3), 11 (a4; passage #1,
P1) and 14 (a5; ESC98B01, P2) days after initiation of cultivation. b1: An 8-cell embryo cultured in KSR ESC medium
with Hs68 feeders. Images show 3 (b2), 4 (b3), 9 (b4; P1), and 18 (b5; ESC98B05, P4) days after initiation of cultivation.
c1: A single blastomere isolated from an 8-cell embryo cultured in KSR ESC medium containing 2i with Hs68 feeders.
Images show 3 (c2), 6 (c3), 9 (c4; P1), and 14 (c5; ESC98B04, P3) days after initiation of cultivation. The bar represents
100 μm. (Reproduced from Lee et al., 2012. Stem Cells and Development 21:373–383.)
3.2. Feeder cells and medium
The cell lines of STO and Hs68 (Caucasian human newborn foreskin fibroblast; ATCC No.
CRL-1635) as well as primary mEF cells can be used as feeder cells. These cells share the same
growth medium, which comprises DMEM (glucose, 4.5 g/L) containing 10% FBS, penicillin (50
unit/mL), and streptomycin (50 μg/mL).
After mitotic inactivation by 10 μg/mL mitomycin C for 2–3 h, single trypsinized cells via 0.25%
trypsin-EDTA are used to prepare feeder layers directly or are frozen until thawed for feeder
preparation. Up to 32 10-μL feeder droplets on a 60-mm cell culture dish, covered with heavy
weight paraffin oil, is prepared 1–2 days before denuded embryos or isolated blastomeres are
seeded.
No difference existed between STO and Hs68 feeders in the derivation of mESCs [31]. How‐
ever, as STO feeders occasionally detached and curled up during cultivation in 10 μL and 20
μL droplets, Hs68 is usually chosen as the feeder cells. However, propagation of Hs68 is slow
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compared to that of STO. Therefore, STO feeder cells are adopted for the large growing areas
in commercially available cell plates and dishes.
3.3. KSR ESC medium supplemented with 2i and ACTH 1–24
The basal KSR ESC medium contained KnockOut™ DMEM (glucose 4.5 g/L) supplemented
with 20% KSR, 0.1 mM non-essential amino acids, 1.75 mM GlutaMAX™-I supplement, 0.1
mM β-mercaptoethanol, penicillin (15.62 unit/mL), streptomycin (15.62 μg/mL), and LIF (1,000
unit/mL). The KnockOut™ DMEM can be replaced by conventional DMEM or (KnockOut™)
DMEM/F12.
Although media prepared from powder are far cheaper than using liquid directly, experiments
always use embryo- or cell culture-tested grades liquid media or solutions, as they are more
consistent and efficient for derivation of mESCs, especially when KSR ESC media are used in
cultivations. The variable quality of homemade ultrapure ddH2O might prove problematic.
However, once the mESCs established, the media prepared from powder could be used for
routine cultivation.
To enhance the successful derivation of mESCs, the basal KSR ESC medium is supplemented
with 0.5 μM PD0325901 (MEK inhibitor), 3 μM CHIR99021 (GSK3 inhibitor) (2i) [48], and 10
μM ACTH 1–24 (adenylyl cyclase inhibitor) [59].
3.4. Derivation of mouse ES cells
Natural or superovulated 3.5–4.5 dpc morulae and blastocysts are used. Recovered embryos
are washed and placed in the KSOM medium supplemented with 20.85 mM HEPES (HK) at
RT until the next treatment. The zona pellucida of embryos is removed (denuded) in seconds
using acidic Tyrode’s solution. Blastomeres of 2- to 8-cell embryos are separated by incubating
denuded embryos in 0.25% trypsin-EDTA for approximately 3–4 min in a 37°C incubator with
humidified atmosphere of 5% CO2 in air, followed by gentle pipetting using a mouth pipette.
The blastomeres and denuded embryos or hatched (naked) blastocysts are washed and then
plated into 10-μL feeder droplets (P0) in KSR ESC medium supplemented with 2i and ACTH
1–24, which is exchanged 1–2 h earlier. Embryos and blastomeres are cultured in a 37°C
incubator with 5% CO2 in air. Following attachment of embryos or blastomeres to the feeder
cells, the media are exchanged at the second or third day. Thereafter, the media are exchanged
every 1 to 2 days.
After culturing for 6 ± 2 d (for whole embryos) or 9 ± 2 d (for blastomeres), individual three-
dimensional outgrowth is identified visually. The feeder cells and flat growing cells are
removed mechanically by a mouth pipette. The outgrowth in the same droplet is washed with
TrypLE™ Express once and then incubated with TrypLE™ Express in a 37°C incubator for
approximately 13 ± 3 min. The outgrowth is washed with KSR ESC medium once and then
disaggregated into clumps and single cells, which are reseeded onto fresh 20-μL droplets (P1).
After 4 ± 1 d, only morphologically mES-like colonies are then passed (via TrypLE Express) to
fresh 1 or 2 wells of 4-well cell plates (P2), and thereafter to either 4-well plates or 35-mm cell
culture dishes (P3) depending on the number of cells. Once mES-like cells are growing in 4-
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well plates and larger dishes, KSR ESC medium (2i + ACTH 1–24 is option) is used for
subsequent propagation. At passages 5 ± 2, mES-like cells are frozen in FBS supplemented with
10% (v/v) dimethyl sulfoxide (DMSO). The typical duration of the above-described process of
mESC derivation (from embryos to freezing of subconfluent 35 mm-dishes) is ranging from
14 to 20 days.
Practically, the first 2–3 passages are critical for successful derivation of mESCs. This protocol
suggests that one use KSR ESC medium containing 2i + ACTH 1–24 only for the first 10-μL
droplets for embryo outgrowth (P0) and second (for single cells and clumps of digested
outgrowths, P1) and/or third 20-μL (for mES-like cells, P2) droplets. Once mES-like cells are
growing on 4-well plates (P2–3), KSR ESC medium is used thereafter for all following culti‐
vations.
The success rates in establishing B6 mESCs by this simple protocol are always greater than
50% for 2.5–4.5 dpc embryos. This efficiency is comparable to that achieved in two other studies
[56,109] and much better than those in many other studies [32,38,61,82,103-108]. This proposed
protocol has a simple layout, is easy to operate, is highly efficient, is reproducible, and can be
an alternative method for establishing mES cell lines routinely.
4. Conclusions
Zygotes to hatched embryos and blastomeres, ICMs, and the epiblasts of early-stage pre-
implantation embryos can be used to establish mESCs. Both embryos and blastomeres have
an extremely high capability for cell division and differentiation. Theoretically, chemical
cocktails that can completely inhibit endogenous differentiation, increase cell division, and
decrease apoptosis of pre-implantation embryos can be helpful to maximize the derivation
efficiency of ESCs.
Culturing pre-implantation embryos, no matter what strains, on a very small surface area
coated with feeder cells in a chemically defined medium supplemented with differentiation
inhibitors (e.g., 2i) and/or proliferation enhancers/stimulators (e.g., LIF and ACTH 1–24) can
be used as a routine protocol to establish mESCs efficiently and reproducibly (always more
than 50%, occasionally reaching 100%). Unfortunately, the same protocol when using 1/8
blastomeres to derive mESCs is merely acceptable (10–25%). Obviously, the possibility to
increase the efficiency of deriving mESCs from whole embryos is limited and unexciting unless
novel differentiation inhibitors or proliferation enhancers/stimulators reveal the effectiveness
of using 1/8 blastomeres and embryos from species other than rodents.
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